We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $2.12B
1-Year Est. Return 32.36%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+32.36%
3 Year Est. Return
+93.72%
5 Year Est. Return
+113.14%
10 Year Est. Return
+557.09%
AUM
$1.45B
AUM Growth
+$74.6M
Cap. Flow
-$319M
Cap. Flow %
-22.04%
Top 10 Hldgs %
32.55%
Holding
126
New
17
Increased
24
Reduced
47
Closed
15

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.98%
2 Technology 18.63%
3 Healthcare 14.93%
4 Financials 13.13%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGG icon
51
Chegg
CHGG
$81.9M
$4.64M 0.32%
+122,540
New +$4.29M
KTOS icon
52
Kratos Defense & Security Solutions
KTOS
$8.76B
$4.41M 0.31%
244,985
+25,245
+11% +$468K
SLAB icon
53
Silicon Laboratories
SLAB
$7.34B
$4.19M 0.29%
36,110
+2,495
+7% +$274K
GOOGL icon
54
Alphabet (Google) Class A
GOOGL
$4.24T
$4.14M 0.29%
61,880
+80
+0.1% +$5.16K
TNDM icon
55
Tandem Diabetes Care
TNDM
$1.17B
$3.91M 0.27%
65,665
+34,990
+114% +$2.16M
PLAN
56
DELISTED
Anaplan, Inc.
PLAN
$3.9M 0.27%
+74,345
New +$3.69M
IOVA icon
57
Iovance Biotherapeutics
IOVA
$4.36B
$3.83M 0.26%
138,325
-12,085
-8% -$275K
ENV
58
DELISTED
ENVESTNET, INC.
ENV
$3.82M 0.26%
+54,825
New +$3.56M
PODD icon
59
Insulet
PODD
$9.74B
$3.55M 0.25%
20,735
-7,645
-27% -$1.27M
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.4M 0.24%
+209,780
New +$3.25M
ENVA icon
61
Enova International
ENVA
$4.35B
$3.34M 0.23%
138,990
-153,270
-52% -$3.45M
LLY icon
62
Eli Lilly
LLY
$1.02T
$3.14M 0.22%
23,875
-55
-0.2% -$6.38K
PG icon
63
Procter & Gamble
PG
$341B
$3.09M 0.21%
24,707
-490
-2% -$60K
VCEL icon
64
Vericel Corp
VCEL
$2.06B
$3M 0.21%
172,220
-34,175
-17% -$582K
RPD icon
65
Rapid7
RPD
$852M
$2.96M 0.2%
52,810
-74,355
-58% -$3.87M
GH icon
66
Guardant Health
GH
$23.8B
$2.7M 0.19%
+34,530
New +$2.49M
BLBD icon
67
Blue Bird Corp
BLBD
$1.99B
$2.62M 0.18%
114,431
-1,158,748
-91% -$23.2M
BRK.A icon
68
Berkshire Hathaway Class A
BRK.A
$1.11T
$2.38M 0.16%
7
YETI icon
69
Yeti Holdings
YETI
$2.96B
$2.34M 0.16%
+67,340
New +$2.12M
AAPL icon
70
Apple
AAPL
$4.87T
$2.32M 0.16%
31,588
+64
+0.2% +$4.12K
FND icon
71
Floor & Decor
FND
$4.97B
$2.12M 0.15%
41,755
-10,350
-20% -$485K
FRC
72
DELISTED
First Republic Bank
FRC
$2.09M 0.14%
17,792
LVGO
73
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$2M 0.14%
+79,980
New +$1.91M
IWO icon
74
iShares Russell 2000 Growth ETF
IWO
$14.2B
0
EVER icon
75
EverQuote
EVER
$858M
$1.77M 0.12%
+51,650
New +$1.44M

Similar funds

Osterweis Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Osterweis Capital Management held 126 positions worth $1.45B, up 5.4% from $1.37B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Osterweis Capital Management withdrew a net $319M in Q4 2019, closing 15 positions and reducing 47 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Osterweis Capital Management opened a new position in Advanced Micro Devices worth $28.9M.

  • Osterweis Capital Management's largest Q4 2019 buy was Advanced Micro Devices: 629,080 shares worth $28.9M.
  • Osterweis Capital Management added most to Charles Schwab in Q4 2019, an estimated $10.2M increase.
  • Osterweis Capital Management's biggest Q4 2019 reduction was Blue Bird Corp, cutting an estimated $23.2M.
  • Osterweis Capital Management fully exited Unilever NV New York Registry Shares in Q4 2019, selling an estimated $25.6M.
  • Osterweis Capital Management's ten largest holdings make up 33% of its $1.45B portfolio in Q4 2019.
  • Osterweis Capital Management opened 17 new positions and closed 15 in Q4 2019.
  • Osterweis Capital Management's portfolio value rose 5.4% quarter-over-quarter to $1.45B.

Based on Osterweis Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.